IO Biotech prepares for IPO in the US

IO Biotech, which is based in Copenhagen, has begun the preparations for a listing in the US. Less than a year ago, the biotech company brought in USD 147.2m (DKK 944m) in a series B funding round.
Photo: Andreas Gebert/Reuters/Ritzau Scanpix
Photo: Andreas Gebert/Reuters/Ritzau Scanpix
BY CHRISTOPHER DUE KARLSSON, TRANSLATED BY DANIEL PEDERSEN

Copenhagen-based biotech company IO Biotech seeks a listing in the US, reports Danish financial daily Børsen, referring to a filing that the firm has sent to the US Securities and Exchange Commission (SEC).

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading